Upregulation of ephrinA1 and ephA2 in CRS patient is consistent with their upregulation, which has been reported in a variety of inflammatory diseases such as pulmonary inflammation and inflammatory bowel disease (30, 31, 43, 44). The gene discussed is EPHA2; the disease is inflammatory bowel disease.